{"id":"https://openalex.org/W2921786593","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.5595","title":"Molecular profile comparison of endometrial, renal and ovarian clear cell carcinoma: Is it the same disease at different sites?","display_name":"Molecular profile comparison of endometrial, renal and ovarian clear cell carcinoma: Is it the same disease at different sites?","publication_year":2015,"publication_date":"2015-05-20","ids":{"openalex":"https://openalex.org/W2921786593","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.5595","mag":"2921786593"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2015.33.15_suppl.5595","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.5595","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.5595","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062339261","display_name":"Robert L. Debernardo","orcid":"https://orcid.org/0000-0002-4359-9063","observed_orcids":["https://orcid.org/0000-0002-4359-9063"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Debernardo","raw_affiliation_strings":["Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089239939","display_name":"Haider Mahdi","orcid":"https://orcid.org/0000-0002-6343-5314","observed_orcids":["https://orcid.org/0000-0002-6343-5314"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haider Mahdi","raw_affiliation_strings":["Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kenneth Russell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenneth Russell","raw_affiliation_strings":["Caris Life Sciences, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Caris Life Sciences, Basel, Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080544645","display_name":"Joanne Xiu","orcid":"https://orcid.org/0000-0001-8744-5827","observed_orcids":["https://orcid.org/0000-0001-8744-5827"]},"institutions":[{"id":"https://openalex.org/I4210140103","display_name":"Caris Life Sciences (United States)","ror":"https://ror.org/04wh5hg83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140103"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joanne Xiu","raw_affiliation_strings":["Caris Life Sciences, Phoenix, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Caris Life Sciences, Phoenix, AZ","institution_ids":["https://openalex.org/I4210140103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046522995","display_name":"Sherri Z. Millis","orcid":"https://orcid.org/0000-0002-5048-6841","observed_orcids":["https://orcid.org/0000-0002-5048-6841"]},"institutions":[{"id":"https://openalex.org/I4210140103","display_name":"Caris Life Sciences (United States)","ror":"https://ror.org/04wh5hg83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140103"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sherri Z. Millis","raw_affiliation_strings":["Caris Life Sciences, Phoenix, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Caris Life Sciences, Phoenix, AZ","institution_ids":["https://openalex.org/I4210140103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077908907","display_name":"Sandeep K. Reddy","orcid":"https://orcid.org/0000-0002-1458-6853","observed_orcids":["https://orcid.org/0000-0002-1458-6853"]},"institutions":[{"id":"https://openalex.org/I4210140103","display_name":"Caris Life Sciences (United States)","ror":"https://ror.org/04wh5hg83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140103"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandeep K. Reddy","raw_affiliation_strings":["Caris Life Sciences, Phoenix, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Caris Life Sciences, Phoenix, AZ","institution_ids":["https://openalex.org/I4210140103"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021894535","display_name":"Michael Leonard Friedlander","orcid":"https://orcid.org/0000-0003-3090-795X","observed_orcids":["https://orcid.org/0000-0003-3090-795X"]},"institutions":[{"id":"https://openalex.org/I4210108821","display_name":"Prince of Wales Hospital","ror":"https://ror.org/022arq532","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210108821"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Michael Friedlander","raw_affiliation_strings":["Prince of Wales Cancer Centre, Randwick, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prince of Wales Cancer Centre, Randwick, Australia","institution_ids":["https://openalex.org/I4210108821"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"15_suppl","first_page":"5595","last_page":"5595"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.5684000253677368,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.5684000253677368,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.16670000553131104,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.06700000166893005,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clear-cell-carcinoma","display_name":"clear cell carcinoma","score":0.9929999709129333},{"id":"https://openalex.org/keywords/ovarian-clear-cell-carcinoma","display_name":"ovarian clear cell carcinoma","score":0.8659999966621399},{"id":"https://openalex.org/keywords/clear-cell-renal-cell-carcinoma","display_name":"clear cell renal cell carcinoma","score":0.9190000295639038},{"id":"https://openalex.org/keywords/molecular-profiling","display_name":"molecular profiling","score":0.7409999966621399},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.7929999828338623},{"id":"https://openalex.org/keywords/pik3ca","display_name":"PIK3CA","score":0.7929999828338623},{"id":"https://openalex.org/keywords/pten","display_name":"PTEN","score":0.9700000286102295},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.8960000276565552},{"id":"https://openalex.org/keywords/vhl-mutation","display_name":"VHL mutation","score":0.828000009059906},{"id":"https://openalex.org/keywords/hormone-receptor-expression","display_name":"hormone receptor expression","score":0.6959999799728394},{"id":"https://openalex.org/keywords/androgen-receptor","display_name":"androgen receptor","score":0.6549999713897705},{"id":"https://openalex.org/keywords/topoisomerase-ii-alpha","display_name":"TOP2A","score":0.7509999871253967},{"id":"https://openalex.org/keywords/thymidylate-synthase","display_name":"thymidylate synthase","score":0.8970000147819519},{"id":"https://openalex.org/keywords/rrm1","display_name":"RRM1","score":0.8199999928474426},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.44600000977516174},{"id":"https://openalex.org/keywords/parp-1","display_name":"PARP1","score":0.30399999022483826},{"id":"https://openalex.org/keywords/parp2","display_name":"PARP2","score":0.734000027179718}],"concepts":[{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.8701360821723938},{"id":"https://openalex.org/C2778560582","wikidata":"https://www.wikidata.org/wiki/Q18347894","display_name":"Clear cell","level":3,"score":0.78635573387146},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7412739992141724},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.720302939414978},{"id":"https://openalex.org/C2781199814","wikidata":"https://www.wikidata.org/wiki/Q18556242","display_name":"Clear cell carcinoma","level":3,"score":0.5716215968132019},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5484042763710022},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.4540773332118988},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.45349299907684326},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.4525659382343292},{"id":"https://openalex.org/C2777088508","wikidata":"https://www.wikidata.org/wiki/Q944777","display_name":"Endometrial cancer","level":3,"score":0.4445459246635437},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.43762728571891785},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43110817670822144},{"id":"https://openalex.org/C78795084","wikidata":"https://www.wikidata.org/wiki/Q5113900","display_name":"Chromophobe cell","level":4,"score":0.4310145974159241},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.39430665969848633},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3890266418457031},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.3618292808532715},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32880890369415283},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21321618556976318},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2015.33.15_suppl.5595","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.5595","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.5595","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4308257190","https://openalex.org/W2907108775","https://openalex.org/W2791106312","https://openalex.org/W2299176878","https://openalex.org/W4319067184","https://openalex.org/W4386948803","https://openalex.org/W1986835750","https://openalex.org/W2157595057","https://openalex.org/W1192876005","https://openalex.org/W4399380806"],"abstract_inverted_index":{"5595":[0],"Background:":[1],"Clear":[2,21,41],"cell":[3,22,42,66,70],"carcinomas":[4,32,67],"(CCC)":[5],"are":[6,46,54,68,352,371],"histologically":[7],"similar,":[8],"however":[9],"their":[10],"clinical":[11,36],"course":[12],"varies":[13],"widely":[14],"based":[15],"on":[16,85],"the":[17,166,184,323,337],"organ":[18],"of":[19,30,49,64,96,336,357],"origin.":[20],"uterine":[23],"carcinoma":[24],"(CCUC)":[25],"accounts":[26],"for":[27,308],"approximately":[28],"5%":[29],"endometrial":[31],"and":[33,72,76,109,135,149,159,183,207,217,251,267,277,319,347],"exhibit":[34],"aggressive":[35],"behavior":[37],"with":[38,56,330,377],"poor":[39],"outcomes.":[40],"ovarian":[43,51],"cancers":[44,52],"(CCOCs)":[45],"a":[47,57,115,272],"subtype":[48],"epithelial":[50],"that":[53,98],"chemo-resistant":[55],"poorer":[58],"prognosis":[59],"than":[60,147,215,279],"other":[61],"subtypes.":[62],"70%":[63],"renal":[65],"clear":[69],"(CCRCs),":[71],"respond":[73],"to":[74,93,157,249,355,373,379],"TKIs":[75],"mTOR":[77,167,338],"inhibitors.":[78],"It\u2019s":[79],"unknown":[80],"if":[81],"these":[82,375],"CCC":[83,97,303,367],"rely":[84],"similar":[86],"molecular":[87,324],"pathways.":[88],"Tumor":[89],"profiling":[90,118,325],"was":[91,210,237],"used":[92],"identify":[94],"subsets":[95],"may":[99,342],"benefit":[100,358],"from":[101],"different":[102],"therapies.":[103],"Methods:":[104],"139":[105],"CCUCs,":[106],"409":[107],"CCOCs":[108,148,216,278,320],"94":[110],"CCRCs":[111,150,161,200,220,241,280],"were":[112,196,262,269],"tested":[113],"using":[114],"commercial":[116],"multiplatform":[117],"service":[119],"(Caris":[120],"Life":[121],"Sciences,":[122],"Phoenix,":[123],"AZ).":[124],"Specific":[125],"tests":[126],"performed":[127],"included":[128],"sequencing":[129],"(Sanger,":[130],"NGS),":[131],"protein":[132],"expression":[133],"(IHC)":[134],"gene":[136],"amplification":[137],"(CISH":[138],"or":[139,260,312],"FISH).":[140],"Results:":[141],"CCUCs":[142,158,214,276,318,346],"had":[143,162,305],"more":[144,211,238,353],"TP53":[145],"mutations":[146,164,195],"(40%":[151],"vs":[152,154,172,174,179,181,190,192,202,204,224,226,231,233,243,245,284,286,291,293,298,300],"16%":[153],"14%).":[155],"Compared":[156],"CCOCs,":[160],"fewer":[163],"in":[165,199,213,219,240,264,275,345,359,365],"pathway":[168,186],"(PIK3CA":[169],"\u2013":[170,188,222,229,282,296],"4%":[171],"25%":[173],"40%;":[175],"PTEN":[176],"-":[177,289],"1%":[178],"26%":[180],"3%)":[182],"MAPK":[185,340],"(KRAS":[187],"0%":[189,203],"14%":[191],"11%).":[193],"VHL":[194],"only":[197],"seen":[198,263],"(47%":[201],"0%).":[205],"ER":[206],"PR":[208,228],"overexpression":[209,236],"common":[212,239],"rare":[218],"(ER":[221],"35%":[223],"8%":[225],"0%;":[227],"22%":[230,297],"13%":[232],"2%).":[234,301],"AR":[235],"(26%":[242],"7%":[244],"5%).":[246],"In":[247],"contrast":[248],"CCUC":[250],"CCOC,":[252],"no":[253],"Her2":[254],"alterations":[255],"measured":[256],"by":[257],"IHC,":[258],"ISH":[259],"SEQ":[261],"CCRCs.TOP2A,":[265],"TS":[266,288],"RRM1":[268,295],"expressed":[270],"at":[271],"higher":[273],"rate":[274],"(TOP2A":[281],"81%":[283],"63%":[285],"27%;":[287],"46%":[290],"51%":[292],"16%;":[294],"19%":[299],"All":[302],"types":[304],"some":[306],"immune-positivity":[307],"PD-1":[309],"(73%,47%,":[310],"68%)":[311],"PD-L1":[313],"(13%,":[314],"6%,29%).":[315],"Conclusions:":[316],"While":[317],"share":[321],"similarities,":[322],"shows":[326],"significant":[327],"differences":[328],"compared":[329],"CCRCs.":[331,360],"This":[332],"data":[333],"suggest":[334],"blockade":[335],"and/or":[339],"pathways":[341],"be":[343,356],"important":[344],"CCOCs.":[348],"Further,":[349],"anti-angiogenic":[350],"agents":[351],"likely":[354],"Immunotherapies":[361],"warrant":[362],"further":[363],"investigation":[364],"selected":[366],"patients.":[368],"Future":[369],"studies":[370],"needed":[372],"correlate":[374],"markers":[376],"sensitivity":[378],"chemotherapy.":[380]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2019-03-22T00:00:00"}